AstraZeneca Plc (NASDAQ: AZN)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
AstraZeneca Plc Returns vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
AstraZeneca Plc Company Info
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide.
News & Analysis
Learn about some of the leading cancer stocks in the U.S stock market this year.
Investing in these companies can help you sleep easy at night.
These exchange-traded funds track companies in this biotech space.
These two companies each pay market-beating dividends to shareholders.
These healthcare titans are poised for a strong showing in 2023 and beyond.
These two stocks might go in different directions in the future.
Healthcare is a sector that has proven to be reliable in recessions.
AstraZeneca's new asthma rescue treatment could soon be approved in the United States for adults.
Motley Fool Returns
Market-beating stocks from our award-winning analyst team.
Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 03/23/2023.
Discounted offers are only available to new members. Stock Advisor list price is $199 per year.
Calculated by Time-Weighted Return since 2002. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.
Valuation
Podcast Episodes
Discover why the stock price movement of AstraZeneca may be misleading.
Digesting how the U.K. decision to exit the EU could affect healthcare stocks here and abroad.
Earnings Transcripts
AZN earnings call for the period ending December 31, 2022.
AZN earnings call for the period ending September 30, 2022.
AZN earnings call for the period ending September 30, 2020.
AZN earnings call for the period ending June 30, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.